Searched over 200M research papers
8 papers analyzed
These studies suggest that losartan is generally well-tolerated and safe for treating hypertension, even in patients with other illnesses, with dizziness being the most common side effect, and may also have beneficial effects on liver fibrosis in chronic hepatitis C patients.
20 papers analyzed
Losartan is a widely used antihypertensive medication that functions as an angiotensin II receptor antagonist. It is primarily prescribed for managing high blood pressure, diabetic nephropathy, and left ventricular hypertrophy . Despite its efficacy, certain contraindications must be considered to ensure patient safety.
One of the most critical contraindications for losartan is its use during pregnancy. Losartan, like other angiotensin-receptor antagonists, is associated with serious fetal toxicity when administered during the second and third trimesters. This can lead to adverse outcomes such as fetal renal dysfunction, oligohydramnios, and even fetal death. Therefore, losartan should be strictly avoided in pregnant women.
Patients with severe renal impairment should use losartan with caution. Although losartan is generally well-tolerated in patients with mild to moderate renal insufficiency, it can exacerbate conditions like hyperkalemia, especially in those with compromised renal function . Monitoring of serum potassium levels is recommended to prevent hyperkalemia, which can be life-threatening.
While losartan does not require dosage adjustments in patients with mild hepatic impairment, it should be used cautiously in those with severe liver conditions. The drug is metabolized by the liver, and impaired hepatic function can lead to increased drug levels and potential toxicity.
Losartan has a favorable drug-drug interaction profile, but caution is advised when it is combined with other medications that affect the cytochrome P450 system. Drugs such as phenobarbital, rifampin, and fluconazole can alter losartan metabolism, necessitating careful therapeutic drug monitoring. Additionally, combining losartan with other antihypertensive agents like ACE inhibitors or lithium can lead to increased risks of adverse effects.
Patients with a history of hypotension or those who are volume-depleted should be cautious when starting losartan. The drug can cause significant drops in blood pressure, leading to dizziness and fainting, particularly after the first dose . Ensuring adequate hydration and monitoring blood pressure can mitigate these risks.
Losartan is an effective antihypertensive agent with a generally favorable safety profile. However, its use is contraindicated in pregnant women due to the risk of fetal toxicity, and caution is advised in patients with severe renal or hepatic impairment. Monitoring for hyperkalemia and potential drug interactions is essential to ensure patient safety. By understanding these contraindications, healthcare providers can optimize the therapeutic benefits of losartan while minimizing potential risks.
Most relevant research papers on this topic